Press Release: GenEdit : GenEdit Expands Leadership Team to Advance Targeted Genetic Medicines into Clinical Trials
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #BayArea--GenEdit has appointed Romuald Corbau, Ph.D., as Chief Scientific Officer (CSO) and Aaron Mishel as Chief Financial Officer (CFO).
Read full article »
GenEdit is a California-based biotechnology company that develops and commercializes curative therapies for the treatment of genetic diseases.
Read more